首页 | 本学科首页   官方微博 | 高级检索  
检索        


Identification of CD56 and CD57 by flow cytometry in Ewing’s sarcoma or primitive neuroectodermal tumor
Authors:L J Gardner  J M Polski  R Fallon  C H Dunphy
Institution:(1) Division of Hematopathology, Department of Pathology, Saint Louis University Health Sciences Center, St. Louis, Mo., USA, US;(2) Department of Hematology and Oncology, Cardinal Glennon Children’s Hospital, St. Louis, Mo., USA, US
Abstract: CD56 and CD57 are commonly considered as natural killer and neuroectodermal markers, but their expression has been identified in a wide spectrum of neoplasms including some cases of Ewing’s sarcoma (ES) and primitive neuroectodermal tumor (PNET). We report two cases of small, round blue cell tumor (SRBCT), in which flow cytometry immunophenotyping (FCI) detected strong expression of CD56 and CD57 (one case). Immunohistochemical staining with Leu-19 and Leu-7 confirmed the FI results. Although CD56 and CD57 expression is consistent with ES/PNET, it can be potentially misleading if results of FCI are interpreted in the absence of other findings. These cases suggest the utility of FCI in undifferentiated SRBCT. The literature on CD56 and CD57 expression in ES/PNET is reviewed and discussed. Received: 5 January 1998 / Accepted: 19 February 1998
Keywords:  Ewing’  s sarcoma  Primitive neuroectodermal tumor  Flow cytometry  Immunophenotyping  NCAM  Antigens
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号